Home » Topics » BioWorld Science

BioWorld Science
RSS

Safety of AVI-4557 confirmed in phase I clinical trial

Nov. 12, 2001

Myriad Genetics reviews fiscal Q1 progress

Nov. 12, 2001

Phase II results presented from AeroDose inhaled insulin study

Nov. 12, 2001

Genta to test Genasense in combination with docetaxel for treatment of NSCLC

Nov. 12, 2001

GSK's Trizivir receives Health Canada approval

Nov. 12, 2001

Management of focal spasticity is latest indication granted for Botox in Canada

Nov. 12, 2001

Novel compounds described in recent patent as chemokine IL-8 antagonists

Nov. 9, 2001

Selective COX-2 inhibitors synthesized by Almirall Prodesfarma

Nov. 9, 2001

New series for obesity and sleep disorders disclosed by Actelion

Nov. 9, 2001

Aventis prepares beta-carboline inhibitor of IKK which prolongs cardiac graft survival

Nov. 9, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...